These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Study on the mutations of ahpC genes in M. tuberculosis isoniazid-resistant isolates]. Wu X; Zhang J; Hu Z Zhonghua Jie He He Hu Xi Za Zhi; 1998 Dec; 21(12):727-9. PubMed ID: 11480074 [TBL] [Abstract][Full Text] [Related]
4. Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Heym B; Stavropoulos E; Honoré N; Domenech P; Saint-Joanis B; Wilson TM; Collins DM; Colston MJ; Cole ST Infect Immun; 1997 Apr; 65(4):1395-401. PubMed ID: 9119479 [TBL] [Abstract][Full Text] [Related]
5. Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Kelley CL; Rouse DA; Morris SL Antimicrob Agents Chemother; 1997 Sep; 41(9):2057-8. PubMed ID: 9303417 [TBL] [Abstract][Full Text] [Related]
6. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. Dhandayuthapani S; Zhang Y; Mudd MH; Deretic V J Bacteriol; 1996 Jun; 178(12):3641-9. PubMed ID: 8655566 [TBL] [Abstract][Full Text] [Related]
7. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Rinder H; Thomschke A; Rüsch-Gerdes S; Bretzel G; Feldmann K; Rifai M; Löscher T Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):508-11. PubMed ID: 9764555 [TBL] [Abstract][Full Text] [Related]
8. Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties. Wilson T; de Lisle GW; Marcinkeviciene JA; Blanchardand JS; Collins DM Microbiology (Reading); 1998 Oct; 144 ( Pt 10)():2687-2695. PubMed ID: 9802010 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Baker LV; Brown TJ; Maxwell O; Gibson AL; Fang Z; Yates MD; Drobniewski FA Antimicrob Agents Chemother; 2005 Apr; 49(4):1455-64. PubMed ID: 15793126 [TBL] [Abstract][Full Text] [Related]
11. Regulation of catalase-peroxidase (KatG) expression, isoniazid sensitivity and virulence by furA of Mycobacterium tuberculosis. Pym AS; Domenech P; Honoré N; Song J; Deretic V; Cole ST Mol Microbiol; 2001 May; 40(4):879-89. PubMed ID: 11401695 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. Musser JM; Kapur V; Williams DL; Kreiswirth BN; van Soolingen D; van Embden JD J Infect Dis; 1996 Jan; 173(1):196-202. PubMed ID: 8537659 [TBL] [Abstract][Full Text] [Related]
13. The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China. Liu L; Jiang F; Chen L; Zhao B; Dong J; Sun L; Zhu Y; Liu B; Zhou Y; Yang J; Zhao Y; Jin Q; Zhang X Emerg Microbes Infect; 2018 Nov; 7(1):183. PubMed ID: 30446638 [TBL] [Abstract][Full Text] [Related]
14. ahpC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Wilson TM; Collins DM Mol Microbiol; 1996 Mar; 19(5):1025-34. PubMed ID: 8830260 [TBL] [Abstract][Full Text] [Related]
15. Analysis of the oxyR-ahpC region in isoniazid-resistant and -susceptible Mycobacterium tuberculosis complex organisms recovered from diseased humans and animals in diverse localities. Sreevatsan S; Pan X; Zhang Y; Deretic V; Musser JM Antimicrob Agents Chemother; 1997 Mar; 41(3):600-6. PubMed ID: 9056000 [TBL] [Abstract][Full Text] [Related]
16. A katG S315T or an ahpC promoter mutation mediate Mycobacterium tuberculosis resistance to 2-thiophen carboxylic acid hydrazide, an inhibitor resembling the anti-tubercular drugs Isoniazid and Ethionamide. Franceschelli JJ; Belardinelli JM; Tong P; Loftus B; Recio-Balsells A; Labadié GR; Gordon SV; Morbidoni HR Tuberculosis (Edinb); 2018 Sep; 112():69-78. PubMed ID: 30205971 [TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Deretic V; Philipp W; Dhandayuthapani S; Mudd MH; Curcic R; Garbe T; Heym B; Via LE; Cole ST Mol Microbiol; 1995 Sep; 17(5):889-900. PubMed ID: 8596438 [TBL] [Abstract][Full Text] [Related]
18. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Kiepiela P; Bishop KS; Smith AN; Roux L; York DF Tuber Lung Dis; 2000; 80(1):47-56. PubMed ID: 10897383 [TBL] [Abstract][Full Text] [Related]
19. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing]. Chen X; Ma Y; Jin Q; Jiang GL; Li CY; Wang Q Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436 [TBL] [Abstract][Full Text] [Related]
20. Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC. Nieto R LM; Mehaffy C; Creissen E; Troudt J; Troy A; Bielefeldt-Ohmann H; Burgos M; Izzo A; Dobos KM PLoS One; 2016; 11(11):e0166807. PubMed ID: 27893795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]